Skip to main content

Alejandro Armando Peláez Suárez

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Alejandro Armando Peláez Suárez

Alejandro Armando Peláez Suárez

Alejandro Armando Peláez Suárez

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Carla París Marcet

Carla París Marcet

Research technician
Neuroradiology
Read more
Alba Martín del Rey

Alba Martín del Rey

Research technician
General Surgery
Read more
Alba Crespo-García Mendizabal

Alba Crespo-García Mendizabal

Research technician
Maternal and Fetal Medicine
Read more
Guillem Casas Masnou

Guillem Casas Masnou

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.